Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 333

The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.

Should there be a moratorium on the use of cholesterol lowering drugs?

Open access
Davey Smith, G., Pekkanen, J.·1992·BMJ

Abstract

Recent reviews of the primary prevention of coronary heart disease through lowering cholesterol concen- trations have varied considerably in their evaluation of the benefits of the intervention.[1][2][3][4] The degree of disagreement is surprising as they review essentially the same data, from clinical trials of cholesterol lowering by drugs or by diet.There is agreement about a reduced risk for coronary events, but there are differing interpretations of the increase in mortality from non-cardiovascular causes that has generally been seen.Particular concern was generated by a recent meta-analysis that showed a significantly increased risk of death from accidents and violence when the results of six randomised primary prevention trials were pooled.3Despite the uncertainty an aggressive approach to cholesterol reduction features in most of the official guidelines for the primary prevention of coronary heart disease.`InBritain the introduction of the new general practitioner contract, with its focus on health promotion, is likely to result in an increase in cholesterol testing.High percentages of the British population would become candidates for drug treat- ment if the guidelines currently advanced by some authorities were put into practice.For middle aged men and women with other coronary risk factors the European Atherosclerosis Society recommends a cut off level, above which the use of lipid lowering drugs should be considered,6 well below the mean population cholesterol concentration.0`'2The entry criteria for the expanded clinical evaluation of lovastatin study (EXCEL)"5 would include a third of the British population.[10][11][12]

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/bmj.304.6824.431

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 40 references

Cited by

Metadata

Authors
Davey Smith, G., & Pekkanen, J.
Venue
BMJ
Publisher
BMJ
Published
1992-02-15
Volume
304
Issue
6824
Pages
431-434
ISSN
  • 0007-1447 (ISSN-L)
  • 0959-8138
  • 1468-5833
OpenAlex
W2085709114
Cited by
333
References
40
FWCI
66.38
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Should there be a moratorium on the use of cholesterol lowering drugs? https://app.cochat.ai/papers/10.1136/bmj.304.6824.431
The paper
Davey Smith, G., & Pekkanen, J. (1992). Should there be a moratorium on the use of cholesterol lowering drugs? BMJ. https://doi.org/10.1136/bmj.304.6824.431

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.